<ARTICLE> 5
<LEGEND> This schedule contains summary financial information extracted from 
audited and unaudited internal financial statements and is qualified in its 
entirety by reference to such financial statements. 
</LEGEND>
<CIK>      0001016169
<NAME>     Medi-Ject Corporation
       
                                                  
<PERIOD-TYPE>                 12-MOS                   3-MOS
<FISCAL-YEAR-END>                       DEC-31-1996             DEC-31-1997
<PERIOD-START>                          JAN-01-1996             JAN-01-1997
<PERIOD-END>                            DEC-31-1996             MAR-31-1997
<CASH>                                      9575240                 6303217
<SECURITIES>                                1464277                 3963906
<RECEIVABLES>                                550738                  869636
<ALLOWANCES>                                  12983                   12983
<INVENTORY>                                  351330                  386167
<CURRENT-ASSETS>                           12015191                11713586
<PP&E>                                      1238584                 1305604
<DEPRECIATION>                               642994                  689053
<TOTAL-ASSETS>                             12955791                12696231
<CURRENT-LIABILITIES>                        827765                 1112990
<BONDS>                                        8350                    5267
<PREFERRED-MANDATORY>                             0                       0
<PREFERRED>                                       0                       0
<COMMON>                                      69256                   69596
<OTHER-SE>                                 12050420                11508378
<TOTAL-LIABILITY-AND-EQUITY>               12955791                12696231
<SALES>                                     1837704                  406081
<TOTAL-REVENUES>                            3930859                 1111020<F1>
<CGS>                                       1136272                  270048
<TOTAL-COSTS>                               5001221                 1419482
<OTHER-EXPENSES>                                  0                       0
<LOSS-PROVISION>                                  0                       0
<INTEREST-EXPENSE>                            31934                    3780
<INCOME-PRETAX>                           (2238568)                (582290)
<INCOME-TAX>                                      0                       0
<INCOME-CONTINUING>                       (2238568)                (582290)
<DISCONTINUED>                                    0                       0
<EXTRAORDINARY>                                   0                       0
<CHANGES>                                         0                       0
<NET-INCOME>                              (2238568)                (582290)
<EPS-PRIMARY>                                 (.39)                   (.08)
<EPS-DILUTED>                                 (.39)                   (.08)
<FN>

<F1> Includes interest income of $230,655 for PE 12-31-96 and $139,919 for PE 
     3-31-97.
</FN>